" class="no-js "lang="en-US"> Arup Paul Archives - Pharmtech Focus
Friday, January 27, 2023

Breaking News

BioSenic appoints Yves Sagot as Independent Director Kinnate Biopharma Adds Global Business and Oncology Expertise to Board of Directors Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication New AI Tool Makes Speedy Gene Editing Possible European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer’s disease Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO Chews for Dogs Sharecare Launches VR Program to Improve Well-being of American Workforce Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer Nogra Pharma Announces Out-licensing Agreement with Torii Pharmaceutical for Japan for New Chemical Entity Topical Acne Treatment

Sort by:

Date

Top Post

ProPharma Acquires UK Based Digital Lab Consulting | PTF

ProPharma Acquires UK Based Digital Lab Consulting

ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]

Read more

Appointments

 LovedBy Hires Former AXA Health Executive Arup Paul as Clinical Director | Pharmtech Focus

LovedBy Hires Former AXA Health Executive Arup Paul as Clinical Director

LovedBy, a technology and consultancy business that exists to improve the lives of people, their […]

  1. BioSenic appoints Yves Sagot as Independent Director

    Appointments

     Read more
  2. Kinnate Biopharma Adds Global Business and Oncology Expertise to Board of Directors

    Appointments

     Read more
  3. Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication

    Diseases

     Read more
  4. New AI Tool Makes Speedy Gene Editing Possible

    Diseases

     Read more
  5. European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer’s disease

    Diseases

     Read more